Glycine

Glycine

SCHEMBL2476160

NC1CC1=O.NCC(=O)O

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLRA1 P23415 1/20 0.53
SLC6A9 P48067 1/20 0.53
OR51E2 Q9H255 1/20 0.53
ITGB3 P05106 1/20 0.38
ITGB2 P05107 1/20 0.38
ITGB1 P05556 1/20 0.38
ITGAV P06756 1/20 0.38
ITGA2B P08514 1/20 0.38
ITGA5 P08648 1/20 0.38
ITGB5 P18084 1/20 0.38
ITGAL P20701 1/20 0.38
ABAT P80404 1/20 0.38
SLC6A12 P48065 4/20 0.37
SLC6A11 P48066 4/20 0.37
SLC6A13 Q9NSD5 4/20 0.37
GABRR1 P24046 8/20 0.35
OAT P04181 1/20 0.34
TLR4 O00206 1/20 0.32
PEPD P12955 1/20 0.31
GRIN2D O15399 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10153255 0.76
Glycine SCHEMBL25242169 0.73 GLRA1 (0.40) GLRA1SLC6A9OR51E2ITGB3ITGB2
Glycine SCHEMBL2116443 0.72
Glycine SCHEMBL93765 0.72 GLRA1 (1.00) GLRA1SLC6A9OR51E2SLC6A12SLC6A11
Glycine SCHEMBL30179260 0.72
Glycine SCHEMBL391027 0.72 GLRA1 (1.00) GLRA1SLC6A9OR51E2SLC6A12SLC6A11
Glycine SCHEMBL6675874 0.72 GLRA1 (1.00) GLRA1SLC6A9OR51E2SLC6A12SLC6A11
Glycine SCHEMBL3640989 0.72 GLRA1 (1.00) GLRA1SLC6A9OR51E2SLC6A12SLC6A11
Glycine SCHEMBL391786 0.72 GLRA1 (1.00) GLRA1SLC6A9OR51E2SLC6A12SLC6A11
Glycine SCHEMBL6163 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107404921-B Sugar-dipeptide conjugates 雀巢产品有限公司 2020-12-25 CN claimed
WO-2020241565-A1 COMPOSITION, GAS SEPARATION MEMBRANE AND METHOD FOR PRODUCING SAME, AND GAS SEPARATION DEVICE 住友化学株式会社 2020-12-03 WO claimed
WO-2020241563-A1 COMPOSITION, GAS SEPARATION FILM AND PRODUCTION METHOD THEREFOR, AND GAS SEPARATION DEVICE 住友化学株式会社 2020-12-03 WO claimed
US-10258071-B2 Sugar-dipeptide conjugates NESTEC S.A. (CH) 2019-04-16 US claimed
EP-3270711-B1 SUGAR-DIPEPTIDE CONJUGATES NESTEC SA (CH) 2018-12-05 EP claimed
US-20180055078-A1 SUGAR-DIPEPTIDE CONJUGATES Société des Produits Nestlé S.A. (CH) 2018-03-01 US claimed
EP-3270711-A1 SUGAR-DIPEPTIDE CONJUGATES Nestec S.A. (CH) 2018-01-24 EP claimed
WO-2016146432-A1 SUGAR-DIPEPTIDE CONJUGATES NESTEC S.A. (CH) 2016-09-22 WO claimed
US-20230390711-A1 RESIN COMPOSITION FOR GAS SEPARATION MEMBRANE AND GAS SEPARATION MEMBRANE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-12-07 US disclosed
US-20230285906-A1 GAS SEPARATION MEMBRANE AND METHOD FOR MANUFACTURING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-09-14 US disclosed
CN-116194197-A Resin composition for gas separation membrane and gas separation membrane 住友化学株式会社 2023-05-30 CN disclosed
EP-4183476-A1 RESIN COMPOSITION FOR GAS SEPARATION MEMBRANE AND GAS SEPARATION MEMBRANE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-05-24 EP disclosed
EP-4183477-A1 GAS SEPARATION MEMBRANE AND METHOD FOR PRODUCING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-05-24 EP disclosed
CN-116133740-A Gas separation membrane and method for producing same 住友化学株式会社 2023-05-16 CN disclosed
US-5585396-A SIDE EFFECT REDUCTION WAKE FOREST UNIVERSITY (US) 1996-12-17 US disclosed
US-5561110-A ADMINISTERING OLIGOPEPTIDE PEPTIDE TECHNOLOGY LIMITED (AU) 1996-10-01 US disclosed
US-5512592-A Method of producing cardiotonic effect and improving cardiac contractile function by administration of carnosine WAKE FOREST UNIVERSITY (US) 1996-04-30 US disclosed
EP-0666753-A1 METHOD FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES PEPTIDE TECHNOLOGY LTD (AU) 1995-08-16 EP disclosed
EP-0666753-A4 METHOD FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES. PEPTIDE TECHNOLOGY LTD (AU) 1995-01-26 EP disclosed
WO-1993004690-A1 METHOD FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES PEPTIDE TECHNOLOGY LIMITED (AU) 1993-03-18 WO disclosed